Press release
Deadline on Dec. 28th coming up in Lawsuit for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN)
A Deadline is coming up on December 28, 2020 in the lawsuit for certain investors in Zosano Pharma Corporation (NASDAQ: ZSAN).
Investors who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and there are strict and short deadlines running. Deadline: December 28, 2020. NASDAQ: ZSAN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Zosano Pharma Corporation (NASDAQ: ZSAN) common shares between February 13, 2017 and September 30, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 13, 2017 and September 30, 2020, the Defendants failed to disclose to investorsthat the Company’s clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots, that pharmocokinetic studies submitted in connection with the Company’s NDA included patients exhibiting unexpected high plasma concentrations of zolmitriptan, that, as a result of the foregoing differences among patient results, the FDA was reasonably likely to require further studies to support regulatory approval of Qtrypta, that, as a result, regulatory approval of Qtrypta was reasonably likely to be delayed, and that as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.
Those who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Dec. 28th coming up in Lawsuit for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN) here
News-ID: 2209538 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Zosano
Rising Research and Vaccine Demand Fueling Microneedle Drug Delivery Systems Mar …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Microneedle Drug Delivery Systems Global Market Report 2023 identifies the increase in research and demand for the vaccination process is the major driver for the microneedle drug delivery systems market's growth in the forecast period. Researchers view microneedle as an alternative way to…
Diabetes Therapy and Drug Delivery Market Projected to Grow at a Steady Pace Dur …
Factors that fuel the market growth are covered in this Diabetes Therapy and Drug Delivery market analysis such as market competition revelation for the forecast period 2021-2027, market advancements, possibilities, technological breakthroughs, latest advancements, challenges and risk solving tips. It covers in-detailed market assessment and estimations about market environment to depict a complete outlook on market evolution. Some of the significant elements covered in this Diabetes Therapy and Drug Delivery…
Cluster Headache Market to Worth $550.1 Million, Growing at 6.4% by 2028 | Zosan …
The global cluster headache market is estimated to be valued at US$ 355.2 Million in 2021 and is expected to increase to US$ 550.1 Million by 2028, witnessing a CAGR of 6.4% over the forecast period (2021-2028).
Cluster headache is one of the most severe type of headache, as it occurs in cyclical patterns or cluster periods. Cluster episodes, which last from weeks to months, are frequently followed by remission periods,…
Microneedle Drug Delivery Systems Market 2021 Global Outlook - 3M, Zosano Pharma …
The “Microneedle Drug Delivery Systems Market” report is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis.
The report is…
Investigation announced for Investors in NASDAQ: ZSAN shares over potential Wron …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Zosano Pharma Corporation.
Investors who are current long term investors in Zosano Pharma Corporation (NASDAQ: ZSAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ZSAN stocks follows a lawsuit filed against Zosano Pharma Corporation…
Lawsuit filed for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN …
An investor, who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN), filed a lawsuit over alleged violations of Federal Securities Laws by Zosano Pharma Corporation.
Investors who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2020. NASDAQ: ZSAN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Fremont, CA based Zosano…
